Crescent Capital Group Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KKR & Co
KKR
|
+$26.8M |
| 2 |
ProShares VIX Short-Term Futures ETF
VIXY
|
+$313K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Airlines Group
AAL
|
+$548K |
| 2 |
EFT
Eaton Vance Floating-Rate Income Trust
EFT
|
+$507K |
| 3 |
BlackRock Floating Rate Income Strategies Fund
FRA
|
+$178K |
| 4 |
CXRX
Concordia International Corp. Common Stock
CXRX
|
+$53 |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 66.22% |
| 2 | Technology | 21.03% |
| 3 | Communication Services | 5.09% |
| 4 | Consumer Discretionary | 4.79% |
| 5 | Healthcare | 1.74% |
Similar funds
Crescent Capital Group's Q2 2016 Portfolio in Review
As of Q2 2016, Crescent Capital Group held 11 positions worth $75.4M, up 33% from $56.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Crescent Capital Group deployed $25.8M of net new capital in Q2 2016, opening 1 new position and adding to 1 existing holding. Its largest new stake was ProShares VIX Short-Term Futures ETF: 19 shares worth $284K.
By sector, the portfolio is most concentrated in Financials at 66% of assets, up from 51% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Eaton Vance Floating-Rate Income Trust, an estimated $507K trimmed.
- Crescent Capital Group's largest Q2 2016 buy was ProShares VIX Short-Term Futures ETF: 19 shares worth $284K.
- Crescent Capital Group added most to KKR & Co in Q2 2016, an estimated $26.8M increase.
- Crescent Capital Group's biggest Q2 2016 reduction was Eaton Vance Floating-Rate Income Trust, cutting an estimated $507K.
- Crescent Capital Group fully exited American Airlines Group in Q2 2016, selling an estimated $548K.
- Crescent Capital Group's ten largest holdings make up 100% of its $75.4M portfolio in Q2 2016.
- Crescent Capital Group opened 1 new position and closed 1 in Q2 2016.
- Crescent Capital Group's portfolio value rose 33% quarter-over-quarter to $75.4M.
Based on Crescent Capital Group's 13F filing for Q2 2016, filed 15 Aug 2016.